Search for Clinical Trial Results
Carcinoid Syndrome - 25 Studies Found
Status | Study |
Withdrawn |
Study Name: Study of Panitumumab in the Treatment of Carcinoid Syndrome Condition: Carcinoid Syndrome Date: 2010-07-28 Interventions: Drug: Panitumumab Panitumumab will be given by intravenous infusion at a dose of 9 mg/kg on day 1 of stu |
Completed |
Study Name: Study of LX1606 in Subjects With Symptomatic Carcinoid Syndrome Condition: Symptoms of Carcinoid Syndrome Date: 2010-04-12 Interventions:
|
Terminated |
Study Name: Comparison of Lanreotide Autogel® and Sandostatin LAR Depot in the Treatment of Clinical Symptoms Associated With Carcinoid Syndrome Condition: Malignant Carcinoid Syndrome Date: 2004-09-22 Interventions:
|
Completed |
Study Name: Effects of Serotonin Excess on Bone in Carcinoid Syndrome Condition: Carcinoid Syndrome Date: 2011-08-26 |
Completed |
Study Name: Telotristat Etiprate for Carcinoid Syndrome Therapy Condition: Carcinoid Syndrome Date: 2014-02-12 Interventions:
|
Terminated |
Study Name: Pharmacokinetics, Efficacy and Safety of an Octreotide Implant in Patients With Carcinoid Syndrome Condition: Carcinoid Syndrome Date: 2009-04-20 Interventions: Drug: Octreotide short acting octreotide |
Completed |
Study Name: An Efficacy and Safety Study of Somatuline Depot (Lanreotide) Injection to Treat Carcinoid Syndrome Condition: Carcinoid Syndrome Date: 2008-10-15 Interventions:
|
Terminated |
Study Name: Study to Assess the Efficacy and Safety of Different Doses of BIM 23A760 in Patients With Carcinoid Syndrome Condition: Carcinoid Syndrome Date: 2009-11-24 Interventions: Drug: BIM 23A760 BIM 23A760 is a solution at a concentration of 5 mg/mL ready for subcutaneous injection |
Completed |
Study Name: TELESTAR (Telotristat Etiprate for Somatostatin Analogue Not Adequately Controlled Carcinoid Syndrome) Condition: Carcinoid Syndrome Date: 2012-08-30 Interventions:
|
Active, not recruiting |
Study Name: Telotristat Etiprate - Expanded Treatment for Patients With Carcinoid Syndrome Symptoms Condition: Carcinoid Syndrome Date: 2013-12-31 Interventions: Drug: Telotristat etiprate tablets (250 mg) Other Name: LX1606 |